Welcome

What is Wellmate?

A mobile app and SaaS for personalized supplement recommendations. Users log current intake and health data; our AI provides evidence-based guidance.

What problem are you solving?

• Overwhelming choice: 10k+ SKUs, mixed evidence, and unclear quality standards.
• Safety uncertainty: limited awareness of drug–supplement and supplement–supplement interactions.
• Low adherence: people lack a simple, personalized plan they can actually follow.
• Wellmate’s answer: evidence-weighted recommendations, interaction checks, and an adherence workflow (tracker + reminders).

Evidence (CustDev, Aug 16 & Aug 20)

• Selection is confusing: respondents describe difficulty comparing products and verifying claims.
• Risk awareness: interactions with medications are a top concern; users want automatic checks.
• Preference for guidance: demand for a single plan tied to goals, not scattered tips.
• Openness to AI: willingness to try AI-guided personalization when transparency and safety flags are provided.

Methodology & raw responses are accessible below (summary tables available in the data room):

• Survey 1 — General Overview of Dietary Supplements (08/16)
• Survey 2 — Needs and Solutions (08/20)

What has been built so far?

• Production iOS/Android apps, backend, CI/CD, analytics, alerts, and observability.
• Core features: goals → plan builder, interaction screening, tracker & reminders, AI guidance.
• Operating cadence: wiki/roadmap, Kanban, release trains, automated QA.
• Early US-heavy user base; demo, dashboards, and cohort metrics are in the data room.

How do you make money?

• B2C subscription for AI-guided personalization and premium features.
• Commerce/affiliate fees from purchases via our catalog with full attribution.
• Brand partnerships (clearly labeled placements) as scale grows.

Note: Any analytics provided to partners are aggregated/de-identified and require explicit user consent (see Privacy FAQ).

Current traction & monetization status

We validated willingness to pay, then temporarily unlocked premium to accelerate acquisition, improve retention, and expand the training/analytics dataset. Re-enablement plan is tied to engagement and cohort targets (D1/D7/D30, plan completion, and conversion). Detailed time series and cohorts are in the data room.

Why a solo founder?

Lean execution and clear ownership at this stage. With traction/funding, we are adding senior leaders (Medical lead, Growth, Data/ML). Open to a complementary operating co-founder with GTM/health credentials.

Who is the founder?

Backend/infra engineer and former team lead in fintech (mobile banking). Conference speaker; strong product orientation. Passionate about evidence-based nutrition. B.Sc. in Computer Science. References available.

Team & advisors

• Experienced engineers (ex-fintech/IT) and growth specialists focused on health/supplements.
• Tester group includes nutritionists/dietitians; industry advisors review key decisions.
• Actively recruiting Head of Medical (MD/PhD) and expanding clinical advisory board.

Privacy & data use

• We do not sell personal data.
• Data are encrypted in transit/at rest; access is role-based and audited.
• Aggregated/de-identified insights are shared only with explicit opt-in and clear purpose.
• Users can export/delete their data from within the app.

Infrastructure, security & data residency

• Primary region: Frankfurt, Germany (GDPR-aligned). Roadmap: regional US/EU deployments for latency/residency.
• Secrets management, periodic backups, and disaster-recovery procedures in place.
• PII minimization and retention policies documented; pen-tests and DPA templates available in the data room.

Regulatory & claims

• Wellmate is a wellness/education product; it does not diagnose, treat, or prescribe.
• Recommendations include levels of evidence and interaction flags; users are prompted to consult clinicians for conditions/medications.
• Marketing and in-app claims follow DSHEA/FTC guidelines; compliance materials are in the data room.

Legal structure & fundraising vehicle

• Entities: Wellmate LTD (UK) and Wellmate, Inc. (Delaware) for US fundraising/partnerships.
• Preferred instrument: YC post-money SAFE (via AngelList). Post-close: countersigned SAFE, funds received, cap table updated; investors receive regular reporting.
• All corporate docs, cap table, and resolutions are in the Legal section of the data room.

Roadmap & strategic options

• Near-term: scale acquisition, deepen personalization, strengthen interaction engine, improve adherence.
• Mid-term: retail/brand partnerships; creator/affiliate programs; expanding specialist network.
• Long-term: independent growth on subscriptions/commerce/partnerships; optional strategic outcomes.
• Milestones and KPI targets (MAU, D30, ARPU/MRR, CAC/payback) are defined quarterly; details in the data room.